Jens Juul Holst

Jens Juul Holst


  1. 2014
  2. Published

    The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance. / van Poppel, P C M; van Asseldonk, E J P; Holst, Jens Juul; Vilsbøll, Tina ; Netea, M G; Tack, C J.

    In: Diabetes, Obesity and Metabolism, Vol. 16, No. 12, 12.2014, p. 1269-73.

    Research output: Contribution to journalLetterResearchpeer-review

  3. Published

    Therapies for inter-relating diabetes and obesity - GLP-1 and obesity. / Iepsen, Eva Pers Winning; Torekov, Signe S; Holst, Jens Juul.

    In: Expert Opinion on Pharmacotherapy, Vol. 15, No. 17, 12.2014, p. 2487-500.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo. / Panaro, Brandon L; Tough, Iain R; Engelstoft, Maja S; Matthews, Robert T; Digby, Gregory J; Møller, Cathrine L; Svendsen, Berit; Gribble, Fiona; Reimann, Frank; Holst, Jens Juul; Holst, Birgitte; Schwartz, Thue W; Cox, Helen M; Cone, Roger D.

    In: Cell Metabolism, Vol. 20, No. 6, 02.12.2014, p. 1018-29.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Pancreatic effects of GLP-1. / Kuhre, Rune Ehrenreich; Albrechtsen, Nicolai Jacob Wewer; Holst, Jens Juul.

    Diapedia: The Living Textbook of Diabetes. European Association for the Study of Diabetes (EASD), 2014.

    Research output: Chapter in Book/Report/Conference proceedingEncyclopedia chapterCommunication

Previous 1...3 4 5 6 7 Next

ID: 4207